TABLE 1

Patient demographics with EORTC-MSG diagnosis of IAa

DemographicbProven/probable IA (n = 19)NEF (n = 42)c
No. of males/no. of females13/625/17
Age (mean [range]) (yr)52.2 (24–73)52.5 (21–78)
Underlying condition (no.)
    AML/MDS1222
    Lymphoma45
    Myeloma6
    ALL12
    AA11
    CML/CLL14
    Other2d
IPA (no.)15None
IPA/sinusitis (no.)4
  • a IA, invasive aspergillosis.

  • b AML, acute myeloid leukemia; MDS, myelodysplastic syndrome; ALL, acute lymphoblastic leukemia; AA, aplastic anemia; CLL, chronic lymphoblastic leukemia; CML, chronic myeloid leukemia; IPA, invasive pulmonary aspergillosis. Lymphoma comprises Hodgkin, non-Hodgkin lymphoma and diffuse large B-cell lymphoma.

  • c NEF, no evidence of fungal disease (control population).

  • d Includes one case of myelofibrosis and one case of combined immunodeficiency with lymphoproliferation.